Novocure home page hero banner featuring innovative cancer treatment technology

together with our patients, we strive to extend survival in some of the most aggressive forms of cancer

Novocure About Us section card with modern blue design and text describing the company

about us

Illustration of NovoTTF-100L Therapy device emitting tumor treating fields for cancer treatment

our therapy

Novocure's oncology drug development pipeline showcasing stages from discovery to commercialization

our pipeline

Diverse group of happy professionals collaborating in a modern office environment

careers

Novocure news and media updates on homepage card

news and media

investor relations

Novocure corporate news banner with modern blue and green geometric shapes

NEWS

Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of TTFields Therapy for Pancreatic Cancer

PANOVA-3 met its primary endpoint with a statistically significant improvement in overall survival for patients with unresectable, locally advanced pancreatic adenocarcinoma treated in the first line with TTFields concomitant with gemcitabine and nab-paclitaxel.

to the press release

patient forward

We are a global oncology company striving to extend survival in some of the most aggressive forms of cancer. Learn more about our company and our mission through stories about patients, our colleagues, our collaborators and our culture.

read all stories

social updates

Stay up to date on our latest news and information by following @Novocure on LinkedIn and Twitter.

Novocure Websites

On this site, videos and images identified as Optune users, caregivers or healthcare professionals depict actual patients, caregivers and healthcare professionals. Patient images reflect the health status of the patients at the time each photo or video was taken.

 

 

 

 



Quick links

about us
our therapy
our pipeline
investors relations
careers
news and media
patient-forward

Novocure logo

© 2025 Novocure GmbH all rights reserved

GLB-CC-00272 v1.0 March 2025